The average market capitalisation cut-off for a stock to make it to the largecap category in the upcoming Amfi semi-annual categorisation is expected to be Rs 84,000 crore compared to an average of Rs 67,000 crore in the six months ending December 2023, Nuvama said in a note. Meanwhile, the midcap threshold is likely to … Read more
The price-to-book value (P/B) for indices on the National Stock Exchange will be calculated based on the networth of each index constituent at the consolidated level in the annual financials, NSE Indices, a subsidiary of the exchange, said in a release on Thursday. Currently, the P/B for indices are calculated by taking into consideration the … Read more
Mankind Pharma, a recent entrant to the stock exchanges, has been included in several Nifty indices, including Nifty500, Nifty Midcap150, Nifty Midcap100 and Nifty200. The decision was taken at a meeting of the index maintenance sub-committee. Mankind Pharma, whose IPO was one of the largest this year, made a healthy debut on the exchanges in … Read more
The Indian equity markets opened on a week note on Monday. However, the benchmark equity indices made a quick recovery to trade higher. Expert: Securities, told ETmarkets.com | Buy | Target Price: Rs 2,610 | Stop Loss: Rs 2,510 | A long position can be initiated in the range of Rs 2,520- 2,535 for the … Read more
Employers will no longer require to deduct GST on the subsidised meal cost recovered from their employees, the Authority of Advance Ruling (AAR) said on Tuesday. The Gujarat bench of the AAR gave the ruling after Zydus Lifesciences approached the authority to seek clarification on whether GST would be levied on the amount deducted from … Read more
The US economy also witnessed substantial issues in its pharma market. In addition to these, manufacturing & exporting countries around the world saw heightened raw material price inflation followed by supply chain disruption. All these affected the margins of the companies deeply. Synopsis Indian pharmaceutical market flattened after the pandemic led to a massive upsurge … Read more
Mumbai: Adani Enterprises has a ‘high chance’ of replacing Shree Cement in the benchmark Nifty in the semi-annual index review in September, according to Edelweiss Alternative & Quantitative Research. The changes in the index will be announced in the second half of August, and the rebalancing date would be on September 30. Abhilash Pagaria, head … Read more
Zydus Lifesciences said on Tuesday said a two-dose regimen of ZyCoV-D will help in administering the vaccine against coronavirus infections to a larger population in a shorter time. The company’s vaccine ZyCoV-D has received emergency use authorisation from the Drug Controller General of India (DCGI) for the two-dose regimen. With the approval, the drug can … Read more